SCYX Q3 2019 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$37M

Q3 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$12M

Net Income

-$8M

EPS (Diluted)

$-1.18

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$449,000

Balance Sheet

Total Assets

$34M

Total Liabilities

$28M

Stockholders' Equity

$6M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$64,000	-100.0%
Gross Profit	$0	$64,000	-100.0%
Operating Income	-$12M	-$6M	-86.5%
Net Income	-$8M	$351,000	-2362.4%